PH30439A - 3,4-Dihydro-2h-1,4-benz-oxazine derivatives and pharmaceutical compositions containing the same - Google Patents

3,4-Dihydro-2h-1,4-benz-oxazine derivatives and pharmaceutical compositions containing the same

Info

Publication number
PH30439A
PH30439A PH43924A PH43924A PH30439A PH 30439 A PH30439 A PH 30439A PH 43924 A PH43924 A PH 43924A PH 43924 A PH43924 A PH 43924A PH 30439 A PH30439 A PH 30439A
Authority
PH
Philippines
Prior art keywords
benz
dihydro
same
pharmaceutical compositions
compositions containing
Prior art date
Application number
PH43924A
Other languages
English (en)
Inventor
Yuzo Matsumoto
Kyuji Tsuzuki
Akira Matsuhisa
Kazuhisa Takayama
Wataru Uchida
Toru Yoden
Masaharu Asano
Isao Yanagisawa
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of PH30439A publication Critical patent/PH30439A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH43924A 1989-11-08 1992-02-23 3,4-Dihydro-2h-1,4-benz-oxazine derivatives and pharmaceutical compositions containing the same PH30439A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP29072789 1989-11-08
JP31592689 1989-12-05
JP34293789 1989-12-28
JP20854890 1990-08-06

Publications (1)

Publication Number Publication Date
PH30439A true PH30439A (en) 1997-05-09

Family

ID=27476415

Family Applications (1)

Application Number Title Priority Date Filing Date
PH43924A PH30439A (en) 1989-11-08 1992-02-23 3,4-Dihydro-2h-1,4-benz-oxazine derivatives and pharmaceutical compositions containing the same

Country Status (11)

Country Link
EP (1) EP0432893A3 (nl)
JP (1) JPH0774208B2 (nl)
KR (1) KR950007757B1 (nl)
AU (1) AU641953B2 (nl)
FI (1) FI905510A0 (nl)
HU (1) HU211282A9 (nl)
IE (1) IE904013A1 (nl)
NO (1) NO904839L (nl)
PH (1) PH30439A (nl)
PT (1) PT95798A (nl)
TW (1) TW224941B (nl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ222843A (en) * 1986-12-22 1989-10-27 Ortho Pharma Corp Benzoxazinyl- and benzothiazinyl-tetrahydropyridazinones and intermediates, and medicaments
CN1060467A (zh) * 1990-09-25 1992-04-22 武田药品工业株式会社 1，3-苯并嗪衍生物、其生产方法和用途
CA2061179A1 (en) * 1991-02-18 1992-08-19 Ryuji Tsuzuki Oxzazinobenzazole compounds
US5262419A (en) * 1992-06-11 1993-11-16 E. R. Squibb & Sons, Inc. Method for the prophylaxis and/or treatment of ulcerative gastrointestinal conditions using a potassium channel activator
JPH06220029A (ja) * 1992-12-03 1994-08-09 Ss Pharmaceut Co Ltd １，４−ベンズオキサジン誘導体
GB9225860D0 (en) * 1992-12-11 1993-02-03 Smithkline Beecham Plc Novel treatment
GB9225859D0 (en) * 1992-12-11 1993-02-03 Smithkline Beecham Plc Novel treatment
AU5979494A (en) * 1993-02-05 1994-08-29 Yamanouchi Pharmaceutical Co., Ltd. Novel benzoxazine derivative, medicine containing the same, and intermediate therefor
GB9309716D0 (en) * 1993-05-12 1993-06-23 Zeneca Ltd Heterocyclic derivatives
KR100254106B1 (ko) * 1994-06-09 2000-05-01 타이도 나오카타 4-퀴놀리논 유도체 또는 그의 염
DE69832176T2 (de) * 1997-08-08 2006-08-03 Chugai Seiyaku K.K. Arzneimittel gegen diabetes-komplikationen
KR100466809B1 (ko) * 1998-06-30 2006-01-27 씨제이 주식회사 즉석닭튀김식품의제조방법
WO2000012492A1 (en) * 1998-09-01 2000-03-09 Nissan Chemical Industries, Ltd. Benzoxazine derivatives
US6455554B1 (en) 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
JPWO2002072049A1 (ja) * 2001-02-27 2004-07-02 山之内製薬株式会社 育毛用医薬組成物
JP2004528335A (ja) * 2001-04-23 2004-09-16 アストラゼネカ アクチボラグ 血管新生の治療に使用のベンゾオキサジノン誘導体
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
CN1678321A (zh) 2002-07-29 2005-10-05 里格尔药品股份有限公司 用2,4－嘧啶二胺化合物治疗或者预防自体免疫性疾病的方法
US7122542B2 (en) 2003-07-30 2006-10-17 Rigel Pharmaceuticals, Inc. Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
DE602005019562D1 (de) * 2004-05-05 2010-04-08 Hoffmann La Roche Zur modulation des 5-ht6-rezeptors, des 5-ht2a-rezeptors oder beider rezeptoren geeignete arylsulfonylbenzodioxane
JP2008514662A (ja) * 2004-09-30 2008-05-08 エフ．ホフマン−ラ ロシュ アーゲー ベンゾオキサジン及びキノキサリン誘導体並びに使用
US7378415B2 (en) 2004-09-30 2008-05-27 Roche Palo Alto Llc Benzoxazine and quinoxaline derivatives and uses thereof
GB0428526D0 (en) 2004-12-30 2005-02-09 Novartis Ag Organic compounds
DK1856135T3 (da) 2005-01-19 2010-04-12 Rigel Pharmaceuticals Inc Prodrugs af 2,4-pyrimidindiamin-forbindelser og deres anvendelser
ES2430139T3 (es) 2005-12-30 2013-11-19 Novartis Ag Compuestos de piperidina 3,5-sustituido como inhibidores de renina
WO2007086504A1 (ja) * 2006-01-27 2007-08-02 Japan Tobacco Inc. カルボン酸化合物及びその用途
TWI385161B (zh) 2006-02-02 2013-02-11 Mitsubishi Tanabe Pharma Corp 含氮雜雙環化合物
EP1984357B1 (en) 2006-02-17 2013-10-02 Rigel Pharmaceuticals, Inc. 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
SG11201402237WA (en) 2011-12-22 2014-09-26 Novartis Ag Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives
CN115181264B (zh) * 2022-07-20 2023-05-23 中国航空工业集团公司济南特种结构研究所 一种苯并噁嗪中间体及其制备方法和聚苯并噁嗪树脂制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1595863C3 (de) * 1966-08-11 1978-03-02 Knoll Ag, 6700 Ludwigshafen 4-Piperidinoacetyl-3,4-dihydro-(2H)-l,4-benioxazin und Verfahren zu dessen Herstellung
GB1173942A (en) * 1967-06-06 1969-12-10 Bellon Labor Sa Roger New 2,3-Dihydro-1,4-Benzoxazines
ATE23718T1 (de) * 1981-09-25 1986-12-15 Beecham Group Plc Benzopyran-verbindungen mit pharmazeutischer wirkung.
JPS61215381A (ja) * 1985-03-22 1986-09-25 Ube Ind Ltd ベンゾオキサジン誘導体および除草剤
NZ222843A (en) * 1986-12-22 1989-10-27 Ortho Pharma Corp Benzoxazinyl- and benzothiazinyl-tetrahydropyridazinones and intermediates, and medicaments
JPS63270678A (ja) * 1987-04-30 1988-11-08 Mitsui Petrochem Ind Ltd 新規含窒素化合物
EP0290863A3 (en) * 1987-05-09 1989-03-15 Nihon Tokushu Noyaku Seizo K.K. Benzoxazine derivative, process and intermediates for its preparation and its use as herbicide
EP0298542B1 (en) * 1987-07-07 1990-12-12 Shell Internationale Researchmaatschappij B.V. Process for preparing thiophene derivatives
GB8800199D0 (en) * 1988-01-06 1988-02-10 Beecham Group Plc Pharmaceutical preparation

Also Published As

Publication number Publication date
HU211282A9 (en) 1995-11-28
AU641953B2 (en) 1993-10-07
TW224941B (nl) 1994-06-11
JPH0774208B2 (ja) 1995-08-09
JPH04178375A (ja) 1992-06-25
AU6594790A (en) 1991-06-06
EP0432893A3 (en) 1991-07-10
NO904839D0 (no) 1990-11-07
FI905510A0 (fi) 1990-11-07
EP0432893A2 (en) 1991-06-19
NO904839L (no) 1991-05-10
KR910009682A (ko) 1991-06-28
KR950007757B1 (ko) 1995-07-14
PT95798A (pt) 1991-09-13
IE904013A1 (en) 1991-05-08

Similar Documents

Publication Publication Date Title
PH30439A (en) 3,4-Dihydro-2h-1,4-benz-oxazine derivatives and pharmaceutical compositions containing the same
IL98393A0 (en) Thiophene derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL108372A0 (en) 2,6-Diaminopurine derivatives, their preparation and pharmaceutical compositions containing them
NZ233320A (en) 3-substituted-2-oxo-indole derivatives and pharmaceutical compositions
HUT74464A (en) 1n-alkyl-n-arylpyrimidinamines and derivatives thereof, and pharmaceutical compositions containing them
IL93090A0 (en) Platinum compounds and pharmaceutical compositions containing the same
IL112193A0 (en) Phenylpyrazolopyridine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
IL110988A0 (en) 4-arylamino-benzopyran derivatives and pharmaceutical compositions containing the same
IL98873A0 (en) Benzodiazepine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL94821A0 (en) Monosaccharide compounds and pharmaceutical compositions containing the same
IL92939A0 (en) Thiazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL99030A0 (en) 1,4-dihydropyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL92425A0 (en) Alpha-d-glucofuranose derivatives,pharmaceutical compositions containing the same and processes for the preparation thereof
NZ233790A (en) Benzocycloalkane derivatives and pharmaceutical compositions
IL88903A0 (en) Indolylpiperidine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL89502A0 (en) Plantinum derivatives and pharmaceutical compositions containing the same
IL95548A0 (en) Thiazole derivatives,processes for the preparation thereof and pharmaceutical composition containing the same
NZ226516A (en) 2,2 dimethylchromene derivatives and pharmaceutical compositions
IL107358A0 (en) a-Phosphonosulfonate derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
IL93321A0 (en) Acetamide derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
NZ232701A (en) Substituted benzoxazolinone derivatives and pharmaceutical compositions
NZ234369A (en) 6-(naphthalenylethyl)-4-hydroxy-pyran-2-one derivatives and the 3,5-dihydroxyheptanoates; pharmaceutical compositions
NZ233013A (en) Substituted thieno-triazolo-diazepine derivatives and pharmaceutical compositions
NZ227235A (en) Substituted 1,5-benzothiazepin-4-one derivatives and pharmaceutical compositions
IL95210A0 (en) 14,17alpha-etheno-and-ethanoestratrienes,process for the preparation thereof and pharmaceutical compositions containing the same